IHC analysis of tumor tissue samples showed that FBXO28 upregulation enhanced the staining of the proliferation-associated genes Ki67 and proliferating cell nuclear antigen (PCNA), with a significantly higher proportion of positive cells in the FBXO28 upregulation group than in the control group. The gene discussed is FBXO28; the disease is neoplasm.